Zobrazeno 1 - 9
of 9
pro vyhledávání: '"S V, Parikh"'
Autor:
G. W. Mattingly, S. J. Mathew, S. V. Parikh, S. T. Aaronson, B. T. Baune, A. Czysz, I. Nandy, V. Ona, C. Brown, S. Kyaga, F. Forrestal, S. Levin, J. Doherty, G. Mattingly
Publikováno v:
European Psychiatry, Vol 67, Pp S327-S328 (2024)
Introduction Zuranolone (ZRN) is a positive allosteric modulator of both synaptic and extrasynaptic gamma-aminobutyric acid type A receptors and a neuroactive steroid approved as an oral, once-daily, 14-day treatment course for adults with postpartum
Externí odkaz:
https://doaj.org/article/e969c03dc5d642a1b50422d649affe13
Autor:
J. K. Murphy, E. E. Michalak, H. Colquhoun, C. Woo, C. H. Ng, S. V. Parikh, L. Culpepper, C. S. Dewa, A. J. Greenshaw, Y. He, S. H. Kennedy, X.-M. Li, T. Liu, C. N. Soares, Z. Wang, Y. Xu, J. Chen, R. W. Lam
Publikováno v:
Cambridge Prisms: Global Mental Health, Vol 6 (2019)
Global inequity in access to and availability of essential mental health services is well recognized. The mental health treatment gap is approximately 50% in all countries, with up to 90% of people in the lowest-income countries lacking access to req
Externí odkaz:
https://doaj.org/article/1bbe658ce7cd442996046257888ecab4
Autor:
S. V. Parikh
Publikováno v:
Acta psychiatrica Scandinavica. 124(1)
Autor:
S V, Parikh, R W, Lam
Publikováno v:
Canadian journal of psychiatry. Revue canadienne de psychiatrie. 46
The Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the treatment of depressive disorders.A standard guidelines development process was followed.
Publikováno v:
Harvard review of psychiatry. 8(3)
Cost-effective psychotherapeutic interventions can enhance pharmacotherapy and improve outcomes in major depression and schizophrenia, but they are rarely studied in bipolar disorder, despite its often unsatisfactory response to medication alone. Fol
Autor:
H R, Spenser, S V, Parikh
Publikováno v:
Canadian journal of psychiatry. Revue canadienne de psychiatrie. 45(3)
Publikováno v:
The journal of ECT. 14(2)
Propofol is a nonbarbiturate anesthetic induction agent known to have anti-convulsant properties. When used as an anesthetic for electroconvulsive therapy (ECT), it can reduce seizure duration to a significant degree, which may not be fully appreciat
Publikováno v:
Canadian journal of psychiatry. Revue canadienne de psychiatrie. 42
To summarize the quality of evidence for the efficacy of different biological treatments in mania, mixed state, and rapid cycling and to propose guidelines for treatment of these conditions.Articles published on treatment of acute mania, mixed states
Publikováno v:
Canadian journal of psychiatry. Revue canadienne de psychiatrie. 42
To review studies on treatments for bipolar depression and make recommendations for practising clinicians treating patients with bipolar depression.Studies that examined various treatments for bipolar depression were evaluated and rated for evidence